|
||
Articles |
,



Department of Molecular and Cellular Biology and the
Laboratory of Embryonic and Genetic Engineering, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan; and the || Department of Dermatology, Gunma University School of Medicine, Maebashi 371-8511, Japan
To elucidate the role of A1, a new member of the Bcl-2 family of apoptosis regulators active in hematopoietic cell apoptosis, we established mice lacking A1-a, a subtype of the A1 gene in mice (A1-a–/– mice). Spontaneous apoptosis of peripheral blood neutrophils of A1-a–/– mice was enhanced compared with that of either wild-type mice or heterozygous mutants (A1-a+/– mice). Neutrophil apoptosis inhibition induced by lipopolysaccharide treatment in vitro or transendothelial migration in vivo observed in wild-type mice was abolished in both A1-a–/– and A1-a+/– animals. On the other hand, the extent of tumor necrosis factor
–induced acceleration of neutrophil apoptosis did not differ among A1-a–/–, A1-a+/–, and wild-type mice. The descending order of A1 mRNA expression was wild-type, A1-a+/–, and A1-a–/–. Taken together, these results suggest that A1 is involved in inhibition of certain types of neutrophil apoptosis.
Key Words: neutrophil apoptosis A1 bcl-2–related gene gene disruption
This work was partially supported by a Grant-in-Aid for Scientific Research (09470069) from the Ministry of Education, Science, and Culture, Japan.
1 Abbreviations used in this paper: ES, embryonic stem cells; PBN, peripheral blood neutrophils; PEN, peritoneal exudate neutrophils.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| TABLE OF CONTENTS |
|